Literature DB >> 19175797

Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Elzbieta Kolaczkowska1, Barbara Plytycz, Bernd Arnold, Helene Piccard, Ghislain Opdenakker.   

Abstract

Matrix metalloproteinase-9 (MMP-9)/gelatinase B plays an important role in neutrophil infiltration during inflammation and cyclooxygenases (COX-1 and COX-2) and their products are important regulators of inflammation. Recently, we reported that a genetic lack of MMP-9 impairs neutrophil infiltration during early zymosan-induced peritonitis but at later stages (> 24 hr) neutrophils persist in the peritoneal cavity. Here we show that this is the result of impaired apoptosis of MMP-9(-/-)-derived leucocytes. As enhanced COX-1 expression was reported in MMP-9(-/-) mice, we evaluated the hypothesis that altered COX expression induced the above phenomenon as COX-dependent prostaglandins can act either anti-apoptotically (PGE(2)) or pro-apoptotically (PGD(2)). The current data demonstrate that messenger RNA and protein expression of both COX isoforms and their activities are increased in MMP-9(-/-) mice during late peritonitis. Application of selective COX inhibitors revealed enhanced COX-1-dependent PGE(2) production and impaired COX-2-dependent PGD(2) synthesis in MMP-9(-/-) mice. Most importantly, inhibition of COX-1 abolished prolonged neutrophil accumulation in the peritoneal cavity of MMP-9(-/-) mice and increased apoptosis of inflammatory leucocytes. Similarly, weaker apoptosis of MMP-9(-/-) bone marrow neutrophils treated in vitro with zymosan was reversed by COX-1 inhibition. In conclusion, enhanced COX-1 expression is responsible for persistent neutrophil presence in the peritoneum of MMP-9(-/-) mice because of increased synthesis of anti-apoptotic PGE(2). In non-transgenic mice, however, inflammatory leucocytes die apoptotically in the late stages of peritonitis as a result of COX-2-dependent PGD(2) activity. Overall, we show a dependence of COX expression on the presence of MMP-9.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175797      PMCID: PMC2753897          DOI: 10.1111/j.1365-2567.2008.02956.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

Review 1.  COX-2 and the kidney.

Authors:  Raymond C Harris
Journal:  J Cardiovasc Pharmacol       Date:  2006       Impact factor: 3.105

2.  The molecular pathophysiology of subacromial bursitis in rotator cuff disease.

Authors:  Theodore A Blaine; Yang-Soo Kim; Ilya Voloshin; Darwin Chen; Koko Murakami; Seong-Sil Chang; Robert Winchester; Francis Y Lee; Regis J O'keefe; Louis U Bigliani
Journal:  J Shoulder Elbow Surg       Date:  2005 Jan-Feb       Impact factor: 3.019

3.  Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.

Authors:  Alexander V Ovechkin; Neetu Tyagi; Walter E Rodriguez; Melvin R Hayden; Karni S Moshal; Suresh C Tyagi
Journal:  J Appl Physiol (1985)       Date:  2005-08-04

4.  Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

Authors:  B Dubois; S Masure; U Hurtenbach; L Paemen; H Heremans; J van den Oord; R Sciot; T Meinhardt; G Hämmerling; G Opdenakker; B Arnold
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

5.  Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.

Authors:  M Holzhausen; L C Spolidorio; N Vergnolle
Journal:  J Dent Res       Date:  2005-02       Impact factor: 6.116

6.  In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse.

Authors:  A D'Haese; A Wuyts; C Dillen; B Dubois; A Billiau; H Heremans; J Van Damme; B Arnold; G Opdenakker
Journal:  J Interferon Cytokine Res       Date:  2000-07       Impact factor: 2.607

7.  Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.

Authors:  F A Attiga; P M Fernandez; A T Weeraratna; M J Manyak; S R Patierno
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

8.  Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis.

Authors:  Elzbieta Kolaczkowska; Magdalena Chadzinska; Anna Scislowska-Czarnecka; Barbara Plytycz; Ghislain Opdenakker; Bernd Arnold
Journal:  Immunobiology       Date:  2006-02-03       Impact factor: 3.144

9.  Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis.

Authors:  Rosemarijn Renckens; Joris J T H Roelofs; Sandrine Florquin; Alex F de Vos; H Roger Lijnen; Cornelis van't Veer; Tom van der Poll
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

10.  Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.

Authors:  Carlos Medina; Alfredo Santana; Maria Cristina Paz; Federico Díaz-Gonzalez; Esther Farre; Antonio Salas; Marek W Radomski; Enriquie Quintero
Journal:  J Leukoc Biol       Date:  2006-02-14       Impact factor: 4.962

View more
  4 in total

1.  Caspase-9 inhibition decreases expression of Mmp9 during chondrogenesis.

Authors:  A Ramesova; B Vesela; E Svandova; H Lesot; E Matalova
Journal:  Histochem Cell Biol       Date:  2022-01-09       Impact factor: 4.304

2.  Effects of ghrelin on the apoptosis of human neutrophils in vitro.

Authors:  Bin Li; Mian Zeng; Haichong Zheng; Chunrong Huang; Wanmei He; Guifang Lu; Xia Li; Yanzhu Chen; Ruijie Xie
Journal:  Int J Mol Med       Date:  2016-07-06       Impact factor: 4.101

3.  Sanguinarine-Chelerythrine Fraction of Coptis chinensis Exerts Anti-inflammatory Activity in Carrageenan Paw Oedema Test in Rats and Reveals Reduced Gastrotoxicity.

Authors:  Maciej Danielewski; Sylwia Zielińska; Agnieszka Matuszewska; Wojciech Słupski; Maciej Włodarczyk; Izabela Jęśkowiak; Benita Wiatrak; Krzysztof Kowalski; Anna Jezierska-Domaradzka; Piotr Ziółkowski; Adam Szeląg; Beata Nowak
Journal:  Oxid Med Cell Longev       Date:  2022-03-16       Impact factor: 6.543

4.  Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy.

Authors:  Yung-Che Chen; An-Shen Lin; Yu-Chiang Hung; Kuang-Den Chen; Ching-Yuan Wu; Chien-Hao Lie; Chang-Chun Hsiao; Chung-Jen Chen; Shih-Feng Liu; Wen-Feng Fang; Jen-Chieh Chang; Ting-Ya Wang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Sum-Yee Leung; Mao-Chang Su; Meng-Chih Lin
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.